Serological markers in Arabs with lupus nephritis

Area of Science:

• Immunology
• Nephrology
• Rheumatology

Background:

• Systemic lupus erythematosus (SLE) is a complex autoimmune disease with varying clinical manifestations across different ethnic groups.
• Lupus nephritis (LN) is a severe complication of SLE, affecting kidney function.
• Understanding the autoantibody profile in diverse populations is crucial for diagnosis and management.

Purpose of the Study:

• To characterize the autoantibody profile of Arab patients diagnosed with lupus nephritis (LN).
• To identify potential serological markers associated with LN in this specific ethnic cohort.
• To compare autoantibody prevalence in Arab patients with and without LN.

Main Methods:

• Retrospective review of medical records of 42 Arab patients with systemic lupus erythematosus (SLE).
• Categorization of patients into two groups: 21 with LN and 21 without LN.
• Analysis of autoantibody profiles, including anti-dsDNA, anti-RNP, C3 hypocomplementemia, rheumatoid factor, and other specific antibody combinations.

Main Results:

• Most LN patients developed kidney disease within five years of SLE diagnosis.
• C3 hypocomplementemia was significantly correlated with LN, while anti-ribonucleoprotein (RNP) antibodies correlated with non-nephritic SLE.
• Anti-double-stranded DNA (dsDNA) antibodies showed high prevalence in both groups, with no significant difference.
• No significant association was found between rheumatoid factor and LN.
• Specific antibody combinations previously linked to LN in other populations did not correlate with renal disease in this cohort.

Conclusions:

• Arab patients with lupus nephritis do not exhibit a distinctive autoantibody profile compared to non-nephritic SLE patients.
• The study highlights the importance of considering ethnic and racial variations in SLE and LN research.
• Findings contribute valuable data for comparative studies of SLE in different populations.